Permira Announces Substantial Investment in PharmaCord
Summary
Founder and Chief Executive Officer Nitin Sahney and the management team will continue to lead PharmaCord and will remain significant investors in the Company alongside the Permira funds. Terms of the transaction were not disclosed.PharmaCord is a high-growth pharma services company that serves as a commercialization partner for life sciences organizations with the goal of enhancing the patient experience. PharmaCords comprehensive solutions support the patient journey for specialty medications through a range of services that raise awareness, facilitate access to treatment, improve affordability and promote therapy adherence. We are guided by our commitment to innovation and our strength in developing and deploying effective technology-supported solutions to enable our clients to improve the patient experience. Im incredibly proud of what our team has accomplished thus far and look forward to bringing even more services to our clients while capturing the exciting growth opportunities ahead with the benefit and support of a global investor like Permira.Jon Maschmeyer, Partner at Permira, said, Weve been extremely impressed with PharmaCords stellar reputation and the growth the company has achieved under the leadership of Nitin, a visionary founder, as well as his highly experienced and accomplished team.